TY  - JOUR
AU  - Martinez-Lopez, Joaquin
AU  - Alonso, Rafael
AU  - Wong, Sandy W
AU  - Rios, Rafael
AU  - Shah, Nina
AU  - Ruiz-Heredia, Yanira
AU  - Sanchez-Pina, Jose Maria
AU  - Sanchez, Ricardo
AU  - Bahri, Natasha
AU  - Zamanillo, Irene
AU  - Poza, Maria
AU  - Buenache, Natalia
AU  - Encinas, Cristina
AU  - Juarez, Luis
AU  - Miras, Fatima
AU  - Collado, Luis
AU  - Barrio, Santiago
AU  - Martin, Thomas
AU  - Cedena, Maria Teresa
AU  - Wolf, Jeffrey
PY  - 2021
DO  - 10.1186/s13045-021-01135-w
UR  - http://hdl.handle.net/10668/18386
T2  - Journal of hematology & oncology
AB  - The assessment of measurable residual disease (MRD) in bone marrow has proven of prognostic relevance in patients with multiple myeloma (MM). Nevertheless, and unlike other hematologic malignancies, the use of MRD results to make clinical decisions in...
LA  - en
KW  - Measurable residual disease
KW  - Minimal residual disease
KW  - Multiple myeloma
KW  - Clinical Decision-Making
KW  - Disease Management
KW  - Female
KW  - Humans
KW  - Male
KW  - Middle Aged
KW  - Multiple Myeloma
KW  - Neoplasm, Residual
KW  - Prognosis
KW  - Retrospective Studies
KW  - Treatment Outcome
TI  - Making clinical decisions based on measurable residual disease improves the outcome in multiple myeloma.
TY  - research article
VL  - 14
ER  -